2 results
Approved WMOCompleted
Efficacy and safety trial with S 44819 after recent ischemic cerebral Event
Approved WMOCompleted
The primary objective is to evaluate the safety, tolerability, and doselimiting toxicities, and determine the recommended dose for expansionof INCA00186 as monotherapy and of combination treatments of INCA00186 with retifanlimab and/or INCB106385 in…